KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232,000 | -95.5% | 2,000 | -97.3% | 0.00% | -95.2% |
| Q2 2021 | $5,100,000 | -89.4% | 75,000 | -88.0% | 0.02% | -91.2% |
| Q1 2021 | $48,150,000 | +52.9% | 625,000 | +19.0% | 0.24% | +26.5% |
| Q4 2020 | $31,500,000 | +54.0% | 525,000 | +10.5% | 0.19% | +34.0% |
| Q3 2020 | $20,449,000 | +9.7% | 475,000 | +5.6% | 0.14% | -5.4% |
| Q2 2020 | $18,639,000 | +72.4% | 450,000 | +80.0% | 0.15% | +60.2% |
| Q1 2020 | $10,810,000 | – | 250,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |